批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2004/01/23 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
PRIORITY
;Orphan
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2025/07/23 |
SUPPL-21(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2024/11/26 |
SUPPL-19(补充) |
Approval |
Efficacy-New Dosing Regimen |
STANDARD
;Orphan
|
|
|
| 2021/09/27 |
SUPPL-20(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2019/10/30 |
SUPPL-17(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2017/01/23 |
SUPPL-16(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2016/07/29 |
SUPPL-15(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2013/06/05 |
SUPPL-12(补充) |
Approval |
Labeling-Patient Package Insert,Labeling-Container/Carton Labels |
UNKNOWN
|
|
|
| 2013/01/15 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2011/01/07 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2008/12/12 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/02/15 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/04/28 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/04/28 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:ACETYLCYSTEINE; 剂型/给药途径:INJECTABLE;INTRAVENOUS; 规格:6GM/30ML (200MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 021539 |
001 |
NDA |
ACETADOTE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
Yes |
Yes |
AP |
2004/01/23
|
CUMBERLAND PHARMS |
| 200644 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2012/11/07
|
FRESENIUS KABI USA |
| 203173 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2015/03/24
|
RISING |
| 207358 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2016/02/29
|
EUGIA PHARMA |
| 091684 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2017/10/31
|
SAGENT PHARMS INC |
| 208166 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2018/07/20
|
ZYDUS PHARMS |
| 213693 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2022/02/03
|
GLENMARK PHARMS INC |
| 215620 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2022/02/23
|
REGCON HOLDINGS |
| 217182 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2023/04/19
|
ONESOURCE SPECIALTY |
| 218397 |
001 |
ANDA |
ACETYLCYSTEINE |
ACETYLCYSTEINE |
INJECTABLE;INTRAVENOUS |
6GM/30ML (200MG/ML) |
Prescription |
No |
No |
AP |
2024/06/07
|
SOMERSET THERAPS LLC |